Clinical Trial for Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma and Non-Small-Cell Lung (NSCLC).

Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition

Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)

Sex

Male or Female

Age

18+ years

Healthy participants

Visit ClinicalTrials.gov for more information

Eligibility criteria

Inclusion criteria

Participants must meet the following criteria:
1. Have pathologically confirmed Stage IIIB or IIIC NSCLC and not be a candidate for surgical resection or definitive chemoradiation, or Stage IV NSCLC per the AJCC Staging Manual (Version 8.0) and the UICC Staging System (Eighth edition).
2. Participants with non-squamous histology must have documented negative test results for EGFR, ALK, and ROS1 AGAs and no known AGAs in NTRK, BRAF, RET, MET, or other AGAs with approved front-line therapies per local standard of care.
3. Large cell neuroendocrine carcinoma is excluded.
4. Candidate for treatment with pembrolizumab monotherapy per local guidelines.
Tumor has PD-L1 expression in ≥50% of tumor cells (TPS ≥50%) as determined by local testing
Measurable disease based on RECIST v1.1 per investigator.
Resolution of acute effects of any prior therapy to either baseline severity or NCI CTCAE Grade 1 or less (except for AEs not constituting a safety risk in the investigator's judgment), unless otherwise excluded.

Exclusion criteria

Life expectancy of <3 months in the opinion of the investigator.
Any medical or psychiatric condition including recent (within the past year) or active suicidal ideation/behavior or laboratory abnormality that may increase the risk of study participation or make the participant inappropriate for the study.
Participants with any history of another malignancy within 3 years before the first dose of study intervention, or any evidence of residual disease from a previously diagnosed malignancy.
Known or suspected hypersensitivity, intolerance, or contraindication to any excipient contained in the drug formulation of sigvotatug vedotin or pembrolizumab.
Participants with any of the following respiratory conditions:
1. Evidence of noninfectious or drug-induced ILD or pneumonitis
2. Known DLCO (adjusted for hemoglobin) <50% predicted.
3. Grade ≥3 pulmonary disease unrelated to underlying malignancy
Known active CNS lesions are excluded. Participants with definitively treated brain metastases (surgery and/or radiotherapy) may be eligible. Clinically inactive brain metastases of longest diameter <0.5 cm are permitted.
Major surgery (defined as a surgery requiring inpatient hospitalization of at least 48 hours) within 21 days or minor surgery within 7 days prior to first dose of study intervention.
Receipt of a live vaccine within 30 days prior to first dose of study intervention.
Pre-existing peripheral neuropathy Grade ≥2 per NCI CTCAE v5.0.
Uncontrolled diabetes mellitus, defined as HbA1c ≥8.0% or HbA1c between 7.0% and 8.0% with associated diabetes symptoms (polyuria or polydipsia) that are not otherwise explained.
Prior immune-related AE that led to anti-PD-(L)1 treatment discontinuation, required a high-dose steroid taper (≥0.5 mg/kg prednisone or equivalent per day) for >2 weeks, or required treatment with systemic immunosuppressive therapy.
History of autoimmune disease that has required systemic treatment in the past 2 years
Participants with prior solid organ or bone marrow transplantation.
Currently receiving a high-dose steroid (>10 mg prednisone or equivalent per day) or other immune suppressant or has a condition requiring a chronic high-dose steroid or immune suppressant.
Prior and concomitant therapy:
1. Any prior treatment with MMAE-derived drugs or IB6 targeting agents.
2. Prior systemic therapy, including anti-PD-(L)1 therapy, for locally advanced, unresectable, or metastatic NSCLC.
  - (Neo)adjuvant anti-PD-(L)1 is allowed if recurrence or progression occurred ≥9 months after the last dose.
  - Other (neo)adjuvant or definitive therapy is allowed if recurrence or progression occurred ≥6 months after the last dose.
3. Prior radiotherapy to the lung within 6 months of first dose of study intervention, referencing the last date radiotherapy was received.
4. Chemotherapy, biologics, and/or other antitumor treatment with immunotherapy not specifically prohibited that is completed less than 4 weeks prior to first dose of study intervention, or 2 weeks for palliative radiotherapy.
5. Any prior therapy with an immune-oncology agent directed to a stimulatory or co-inhibitory T-cell receptor
History of or current ongoing infection, including participants positive for active HIV, HBV, or HCV.
Severe uncontrolled cardiac or cerebrovascular condition within the previous 6 months

Study overview

The purpose of the study is to compare how the new combination treatment (Sigvotatug Vedotin plus pembrolizumab) works compared to pembrolizumab alone in patients with non-small cell lung cancer (NSCLC) with high levels of PD-L1. This is a protein that acts as a kind of "brake" to keep the body's immune responses under control.

The study is seeking for participants who:

Are confirmed to have NSCLC (Stage 3 or 4).
Have PD-L1 levels in more than 50% of the cancer cells.

All participants in this study will receive pembrolizumab at the study clinic once every 6 weeks as an intravenous (IV) infusion (give directly into a vein). In addition, half of the participants will also receive Sigvotatug Vedotin once every 2 weeks as an IV infusion in addition to receiving pembrolizumab.

Participants may receive pembrolizumab for up to about two years. Those participants taking Sigvotatug Vedotin can continue until their NSCLC is no longer responding. The study team will monitorsee how each participant is doing with the study treatment during regular visits at the clinic.

View locations for this study

Find the closest location, your results will be shown below

Find the closest location

Miles

0500

Nearest Locations found

50 sites found

BRCR Global

Plantation, Florida, United States, 33322

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Cancer Centers of Colorado St. Mary's Regional Hospital

Grand Junction, Colorado, United States, 81501

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Cancer Partners of Nebraska

Lincoln, Nebraska, United States, 68516

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Endeavor Health

Elmhurst, Illinois, United States, 60126

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Endeavor Health

Naperville, Illinois, United States, 60540

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Hennepin County Medical Center

Minneapolis, Minnesota, United States, 55415

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Hope and Healing Cancer Services

Hinsdale, Illinois, United States, 60521

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Hope and Healing Cancer Services

New Lenox, Illinois, United States, 60451

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Intermountain Health

Grand Junction, Colorado, United States, 81505

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Intermountain Health Cancer Center Lutheran Hospital

Golden, Colorado, United States, 80401

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Intermountain Health Lutheran Hospital

Wheat Ridge, Colorado, United States, 80401

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Intermountain Health St. Mary's Regional Hospital

Grand Junction, Colorado, United States, 81501

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Jackson Oncology Associates, PLLC

Jackson, Mississippi, United States, 39202

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Jackson Oncology Associates, PLLC

Jackson, Mississippi, United States, 39216

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

M Health Fairview Cancer Clinic-Edina

Edina, Minnesota, United States, 55435

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

M Health Fairview St. John's Hospital

Maplewood, Minnesota, United States, 55109

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Maine Medical Center

Portland, Maine, United States, 04102

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

MaineHealth Cancer Care - Scarborough

Scarborough, Maine, United States, 04074

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

MaineHealth Cancer Care and Blood Disorders Scarborough

Scarborough, Maine, United States, 04074

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Metro Minnesota Community Oncology Research Consortium (MMCORC)

Saint Louis Park, Minnesota, United States, 55426

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Mid Florida Hematology and Oncology Center

Orange City, Florida, United States, 32763

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Minnesota Oncology Hematology PA

Coon Rapids, Minnesota, United States, 55433

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Minnesota Oncology Hematology PA

Edina, Minnesota, United States, 55435

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Minnesota Oncology Hematology PA

Maple Grove, Minnesota, United States, 55369

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Minnesota Oncology Hematology PA

Maplewood, Minnesota, United States, 55109

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Minnesota Oncology Hematology, P.A. Cornerstone Medical Specialty Center

Woodbury, Minnesota, United States, 55125

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Minnesota Oncology Hematology, PA

Burnsville, Minnesota, United States, 55337

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

North Memorial Health Cancer Center

Robbinsdale, Minnesota, United States, 55422

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Oncology Hematology West P.C. dba Nebraska Cancer Specialists - Methodist

Omaha, Nebraska, United States, 68114

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Oncology Hematology West, PC dba Nebraska Cancer Specialists - Bergan

Omaha, Nebraska, United States, 68124

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Oncology Hematology West, PC dba Nebraska Cancer Specialists - Fremont

Fremont, Nebraska, United States, 68025

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Oncology Hematology West, PC dba Nebraska Cancer Specialists - Grand Island

Grand Island, Nebraska, United States, 68803

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Oncology Hematology West, PC dba Nebraska Cancer Specialists - Regional

Grand Island, Nebraska, United States, 68803

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Park Nicollet Frauenshuh Cancer Center

Saint Louis Park, Minnesota, United States, 55426

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Providence Medical Foundation

Fullerton, California, United States, 92835

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center

Fullerton, California, United States, 92835

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Regions Hospital

Saint Paul, Minnesota, United States, 55101

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Saint Luke's Cancer Institute

Kansas City, Missouri, United States, 64111

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Saint Luke's East Hospital

Lee's Summit, Missouri, United States, 64086

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Saint Luke's Hospital of Kansas City

Kansas City, Missouri, United States, 64111

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Saint Luke's South Hospital

Overland Park, Kansas, United States, 66213

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Southcoast Centers for Cancer Care

Fairhaven, Massachusetts, United States, 02719

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Southcoast Centers for Cancer Care

Fall River, Massachusetts, United States, 02720

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

St. Jude Heritage Medical Group - Fullerton Plaza Multi-Specialty Clinic (Pulmonary Function Test)

Fullerton, California, United States, 92835

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Washington DC Veterans Affairs Medical Center

Washington D.C., District of Columbia, United States, 20422

Recruiting

Site Info

Recruitment Status
Site details
Get direction
Study Contact
Clinical Trials ID

Corewell Health